VEGFA and prostate adenocarcinoma: Although VEGF expression in prostate adenocarcinoma has been shown to be expressed by immunohistochemical (IHC) analysis in various studies, the results in the literature have been markedly variable, with prior studies reporting VEGF expression in approximately 40% to 100% of prostate cancer cases[18-28].